Your browser doesn't support javascript.
loading
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
Eissmann, Moritz F; Dijkstra, Christine; Jarnicki, Andrew; Phesse, Toby; Brunnberg, Jamina; Poh, Ashleigh R; Etemadi, Nima; Tsantikos, Evelyn; Thiem, Stefan; Huntington, Nicholas D; Hibbs, Margaret L; Boussioutas, Alex; Grimbaldeston, Michele A; Buchert, Michael; O'Donoghue, Robert J J; Masson, Frederick; Ernst, Matthias.
Affiliation
  • Eissmann MF; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Dijkstra C; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Jarnicki A; Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Phesse T; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Brunnberg J; Cell Signaling and Cancer Laboratory, European Cancer Stem Cell Research Institute and Cardiff University, Cardiff, CF24 4HQ, UK.
  • Poh AR; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Etemadi N; Institute of Biochemistry, Goethe University Frankfurt, Frankfurt am Main, 60438, Frankfurt, Germany.
  • Tsantikos E; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Thiem S; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Huntington ND; Cell Signalling and Cell Death Division, Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3052, Australia.
  • Hibbs ML; Department of Immunology and Pathology, Monash University, Melbourne, VIC, 3004, Australia.
  • Boussioutas A; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
  • Grimbaldeston MA; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3052, Australia.
  • Buchert M; Department of Immunology and Pathology, Monash University, Melbourne, VIC, 3004, Australia.
  • O'Donoghue RJJ; Department of Medicine, University of Melbourne, Melbourne, VIC, 3050, Australia.
  • Masson F; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, 5000, Australia.
  • Ernst M; OMNI-Biomarker Development, Genentech Inc., South San Francisco, CA, 94080, USA.
Nat Commun ; 10(1): 2735, 2019 06 21.
Article in En | MEDLINE | ID: mdl-31227713
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Interleukin-33 / Macrophages / Mast Cells Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Interleukin-33 / Macrophages / Mast Cells Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2019 Type: Article